EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+12.44%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(+3.9%)
Cap. Flow
-$33.1M
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
65.03%
Holding
329
New
20
Increased
146
Reduced
123
Closed
37
Top Buys
| 1 |
KLA
KLAC
|
$9.71M |
| 2 |
Pinduoduo
PDD
|
$8.56M |
| 3 |
iShares Gold Trust
IAU
|
$3.24M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.14M |
| 5 |
iShares MSCI Global Gold Miners ETF
RING
|
$3.08M |
Top Sells
| 1 |
Grab
GRAB
|
$40.9M |
| 2 |
NVIDIA
NVDA
|
$7.48M |
| 3 |
Microsoft
MSFT
|
$5.75M |
| 4 |
STAAR Surgical
STAA
|
$4.82M |
| 5 |
Sea Limited
SE
|
$3.38M |
Sector Composition
| 1 | Consumer Discretionary | 45.37% |
| 2 | Technology | 25.37% |
| 3 | Communication Services | 8.93% |
| 4 | Healthcare | 6.43% |
| 5 | Real Estate | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Illumina
ILMN
$15.5B
| $316K | 0.02% |
2,301
+354
| +18% | +$48.6K |
|
202
Catalyst Pharmaceutical
CPRX
$2.51B
| $307K | 0.02% |
26,220
-12,218
| -32% | -$143K |
|
203
Diamondback Energy
FANG
$43.4B
| $305K | 0.02% |
1,967
+266
| +16% | +$41.2K |
|
204
Enphase Energy
ENPH
$4.84B
| $303K | 0.02% |
2,526
+131
| +5% | +$15.7K |
|
205
89bio
ETNB
$1.36B
| $303K | 0.02% |
19,621
-1,983
| -9% | -$30.6K |
|
206
Crinetics Pharmaceuticals
CRNX
$3.14B
| $302K | 0.02% |
+10,155
| New | +$302K |
|
207
GlobalFoundries
GFS
$18.4B
| $301K | 0.02% |
5,167
+958
| +23% | +$55.8K |
|
208
McDonald's
MCD
$225B
| $300K | 0.02% |
1,138
-82
| -7% | -$21.6K |
|
209
Protagonist Therapeutics
PTGX
$3.66B
| $300K | 0.02% |
17,991
+2,637
| +17% | +$44K |
|
210
Gartner
IT
$19B
| $298K | 0.02% |
869
+94
| +12% | +$32.2K |
|
211
Bank of America
BAC
$373B
| $295K | 0.02% |
10,789
-790
| -7% | -$21.6K |
|
212
BioCryst Pharmaceuticals
BCRX
$1.74B
| $294K | 0.02% |
41,497
-10,926
| -21% | -$77.4K |
|
213
Arcellx
ACLX
$3.87B
| $293K | 0.02% |
8,156
+407
| +5% | +$14.6K |
|
214
Atlassian
TEAM
$45.3B
| $292K | 0.02% |
+1,447
| New | +$292K |
|
|
ICPT
215
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $292K | 0.02% |
15,728
-6,439
| -29% | -$120K |
|
216
Warner Bros
WBD
$28.8B
| $287K | 0.02% |
26,455
+3,962
| +18% | +$43K |
|
217
Linde
LIN
$222B
| $284K | 0.02% |
762
-56
| -7% | -$20.9K |
|
218
Bristol-Myers Squibb
BMY
$96.5B
| $274K | 0.02% |
4,717
-236
| -5% | -$13.7K |
|
219
Arcus Biosciences
RCUS
$1.15B
| $270K | 0.02% |
15,038
-1,098
| -7% | -$19.7K |
|
220
eBay
EBAY
$41.1B
| $258K | 0.02% |
5,852
+832
| +17% | +$36.7K |
|
221
Dollar Tree
DLTR
$23.2B
| $256K | 0.02% |
2,403
+355
| +17% | +$37.8K |
|
222
Rocket Pharmaceuticals
RCKT
$350M
| $254K | 0.02% |
12,412
-120
| -1% | -$2.46K |
|
223
Vir Biotechnology
VIR
$695M
| $253K | 0.02% |
26,982
+10,220
| +61% | +$95.8K |
|
224
Medtronic
MDT
$120B
| $249K | 0.02% |
3,183
-157
| -5% | -$12.3K |
|
225
CDW
CDW
$21.3B
| $246K | 0.02% |
1,218
-104
| -8% | -$21K |
|